Agonistic Properties of Cannabidiol at 5-HT1a Receptors

@article{Russo2005AgonisticPO,
  title={Agonistic Properties of Cannabidiol at 5-HT1a Receptors},
  author={E. Russo and Andrea Burnett and B. Hall and K. Parker},
  journal={Neurochemical Research},
  year={2005},
  volume={30},
  pages={1037-1043}
}
Cannabidiol (CBD) is a major, biologically active, but psycho-inactive component of cannabis. In this cell culture-based report, CBD is shown to displace the agonist, [3H]8-OH-DPAT from the cloned human 5-HT1a receptor in a concentration-dependent manner. In contrast, the major psychoactive component of cannabis, tetrahydrocannabinol (THC) does not displace agonist from the receptor in the same micromolar concentration range. In signal transduction studies, CBD acts as an agonist at the human 5… Expand

Paper Mentions

News Article
Observational Clinical Trial
The aim of this study is to evaluate the efficacy of oral administration of nabilone or THC/CBD administration in combination with spinal cord stimulation (SCS) in FBSS patients… Expand
ConditionsFBSS
InterventionDrug
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
TLDR
It is confirmed that CBD does not bind with high affinity to the orthosteric site of the human CB2R where the synthetic cannabinoid, [3H]-WIN 55,212-2, binds, and CBD was, however, able to produce minor but consistent reduction in the homogeneous binding assays in living cells using the fluorophore-conjugatedCB2R-selective compound, CM-157. Expand
Cannabidiol and 5-HT1A Receptors
Abstract Cannabidiol (CBD), the major nonpsychotomimetic compound present in the Cannabis sativa plant, is a promising drug to treat several neuropsychiatric and nonneuropsychiatric disorders.Expand
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists
TLDR
Results show that CBD can interfere with food intake changes induced by a CB1 or 5-HT1A receptor agonist, suggesting that its role as a possible food intake regulator should be further investigate. Expand
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists
  • P. Roser, F. Vollenweider, W. Kawohl
  • Medicine
  • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2010
TLDR
Preclinical and clinical studies investigating the potential antipsychotic effects of both CBD and SR141716 are presented together with the possible underlying mechanisms of action. Expand
Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors.
TLDR
CBD inhibits the function of the α7-nACh receptor, a cloned α7 subunit of the human nicotinic acetylcholine (α7 nACh) receptor expressed in Xenopus oocytes, and phytocannabinoids such as cannabinol and Δ(9)-tetrahydrocannabinol did not affect ACh-induced currents. Expand
Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy
TLDR
Evaluated cell membranes show that CBD interacts with human 5-HT1A receptors of the hippocampus and temporal neocortex, and at low concentrations, the effect of CBD upon Gi/o protein activation is limited, however, at high concentrations, CBD acts as an inverse agonist of 5- HT1A receptor. Expand
Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
TLDR
Cannabidiol potentiated pharmacological effects of Delta(9)-THC via CB(1) receptor-dependent mechanism, which may contribute in setting the basis for interaction of cannabinoids and to find a cannabinoid mechanism in central nervous system. Expand
The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes
TLDR
It is suggested that allosteric inhibition of 5-HT3 receptors by CBD may contribute to its physiological roles in the modulation of nociception and emesis. Expand
5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats.
TLDR
Evidence of an interaction between endocannabinoid system and serotonin (5-HT), 1A receptor subtype on anxiety-like behavior in Sprague-Dawley rats is shown, suggesting that the anxiolytic effect produced by endo- and eso-cannabinoids is modulated by 5-HT1A receptors. Expand
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1‐CB2 heteroreceptor complexes
TLDR
For the first time, GPCR biased agonism is characterized in an heteromeric context and was reduced when assays were performed in cells expressing the two receptors, thus suggesting that the heteromer allows less functional selectivity. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
Hallucinogens and serotonergic mechanisms.
TLDR
Using [3H]DOB as radioligand to minimize differences observed between agonists and antagonists, 5-HT2 affinity is related both to the lipophilicity and electron withdrawing nature of the 4-position substituents. Expand
Modulation of cannabinoid agonist binding by 5‐HT in the rat cerebellum
TLDR
A membrane‐delimited cross‐talk between two G protein‐coupled receptors that are co‐localized in certain cells of the central nervous system is supported, and the cannabinoid agonist dependence of the 5‐HT modulatory effect suggests that agonist‐specific conformations of the CB1 receptor may also be important in determining the extent of this cross‐ talk. Expand
The cannabinoid receptors.
  • A. Howlett
  • Chemistry, Medicine
  • Prostaglandins & other lipid mediators
  • 2002
TLDR
The biological activities, pharmacology, and signal transduction mechanisms for the cannabinoid receptors, with particular emphasis on the responses to the eicosanoid ligands are described. Expand
Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors
TLDR
The data presented are consistent with oleamide acting via a cannabinoid recognition site to enhance 5-HT2 receptor function in vivo and the mechanism of the modulation is still unclear but it does not appear to involve a potentiation of 5- HT2 receptor-stimulated phosphoinositide hydrolysis. Expand
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
TLDR
Cannabidiol was more protective against glutamate neurotoxicity than either ascorbate or alpha-tocopherol, indicating it to be a potent antioxidant, and data suggest that the naturally occurring, nonpsychotropic cannabinoid, cannABidiol, may be a potentially useful therapeutic agent for the treatment of oxidative neurological disorders such as cerebral ischemia. Expand
Pharmacology of cannabinoid CB1 and CB2 receptors.
  • R. Pertwee
  • Biology, Medicine
  • Pharmacology & therapeutics
  • 1997
TLDR
This review focuses on the classification, binding properties, effector systems and distribution of cannabinoid receptors, and describes the various cannabinoid receptor agonists and antagonists now available and considers the main in vivo and in vitro bioassay methods that are generally used. Expand
Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors.
TLDR
The hypothesis that oleamide acts via an allosteric site on the 5-HT7 receptor regulating receptor affinity is supported. Expand
Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.
TLDR
An interesting set of analogs was identified that inhibit rather than potentiate the 5-HT2A, but not the5-HT1A, receptor response, further suggesting that such analogs may permit the selective modulation of serotonin receptor subtypes and even have opposing effects on the different subtypes. Expand
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
TLDR
Results suggest that VR1 receptors, or increased levels of endogenous AEA, might mediate some of the pharmacological effects of CBD and its analogues, and (−)‐5′‐DMH‐CBD represents a valuable candidate for further investigation as inhibitor of AEA uptake and a possible new therapeutic agent. Expand
Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.
TLDR
CBD was efficient in blocking most of the effects of Δ9-THC when both drugs were given together and decreased the anxiety component of Δ 9-THc effects, in such a way that the subjects reported more pleasurable effects. Expand
...
1
2
3
4
5
...